Average Co-Inventor Count = 6.10
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Pharma Company (11 from 234 patents)
2. Dupont Pharmaceuticals Company (6 from 106 patents)
3. Other (2 from 832,843 patents)
4. Bristol-myers Squibb Compnay (2 from 3,684 patents)
5. E.i. Dupont De Nemours and Company (1 from 16,338 patents)
6. Bristol-myers Squibb Pharma Corporation (1 from 10 patents)
23 patents:
1. 7655647 - Substituted lactams as inhibitors of Aβ protein production
2. 7498324 - Substituted lactams as inhibitors of Aβ protein production
3. 7390802 - Substituted lactams as inhibitors of Aβ protein production
4. 7276495 - Substituted lactams as inhibitors of Aβ protein production
5. 7235575 - Guanidine mimics as factor Xa inhibitors
6. 6906070 - Guanidine mimics as factor Xa inhibitors
7. 6900199 - Substituted lactams as inhibitors of Aβ protein production
8. 6858616 - Nitrogen containing heterobicycles as factor Xa inhibitors
9. 6673810 - Imidazo-heterobicycles as factor Xa inhibitors
10. 6632812 - Substituted lactams as inhibitors of A&bgr; protein production
11. 6602895 - Inhibitors of factor Xa with a neutral P1 specificity group
12. 6602871 - Thrombin or factor Xa inhibitors
13. 6552042 - Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor Xa
14. 6548512 - Nitrogen containing heteroaromatics as factor Xa inhibitors
15. 6413980 - Nitrogen containing heterobicycles as factor Xa inhibitors